After going through 500 genetic reports again over the last few days, one of the most consistent patterns I see is instability in how the nervous system regulates and clears its own chemistry.
After going through 500 genetic reports again over the last few days, one of the most consistent patterns I see is instability in how the nervous system regulates and clears its own chemistry. People come in describing anxiety, racing thoughts, poor sleep, mood swings, sensitivity to stress, and a sense that their body shifts states quickly. What shows up in their genetics is not a simple deficiency. It is a pattern of inconsistent neurotransmitter breakdown.
The primary pathways involved are COMT, MAOA, and methylation. These systems are responsible for clearing neurotransmitters after they are released. Dopamine, epinephrine, and norepinephrine are not meant to stay elevated for long periods. They are released in response to stimuli, perform their signaling role, and then must be deactivated in a controlled and timely way. This clearance step is what determines whether the nervous system feels stable or reactive.
COMT uses methyl groups to deactivate catecholamines. Its activity is directly tied to the availability of SAMe, which is generated through the methylation cycle. MAOA uses cofactors including riboflavin and iron to break down monoamines such as serotonin and dopamine. These enzymes do not function in isolation. They depend on a network of nutrient-driven reactions that determine how efficiently neurotransmitters are cleared.
In a large portion of the reports, COMT shows reduced or variable activity. MAOA often shows altered function alongside it. Methylation-related SNPs such as MTHFR, MTR, and others indicate fluctuations in methyl donor availability. This creates a system where neurotransmitters are not cleared at a consistent rate.
What this looks like clinically is a cycling nervous system. Many individuals report feeling overstimulated after small amounts of caffeine, reacting strongly to stress, or feeling mentally “on” late into the night. The same individuals may also report periods of low motivation, fatigue, or mental fog. These are not separate conditions. They are different expressions of the same underlying instability in neurotransmitter clearance.
A common pattern across reports is sensitivity to inputs that affect methylation. Some individuals feel worse when taking high-dose methyl donors. Others feel unstable when methylation is under-supported. This reflects the dynamic nature of the system. When methylation flow increases, COMT activity can increase, leading to faster breakdown of neurotransmitters. When methylation slows, clearance slows. The nervous system follows these shifts.
Another consistent finding is the role of redox balance. Vitamin C appears repeatedly as a central regulator. It supports dopamine beta-hydroxylase, influences adrenal signaling, and helps buffer oxidative stress generated during neurotransmitter metabolism. When redox capacity is low, neurotransmitter signaling becomes more reactive and less controlled. This adds another layer of variability to the system.
Magnesium is also a key factor. It stabilizes NMDA receptor activity and reduces excitatory signaling. Low magnesium status increases neuronal excitability, making the effects of fluctuating neurotransmitters more pronounced. Riboflavin supports MAOA activity and overall mitochondrial function, which is necessary for maintaining energy balance in neurons.
In many of the reports, these nutrient dependencies are not aligned with the individual’s genetic demand. This does not mean the person is severely deficient. It means the margin for stability is smaller. Small changes in intake, stress, sleep, or environment can shift the system.
This explains why many people describe feeling fine for a period of time and then suddenly dysregulated without a clear cause. The underlying pathways are sensitive, and their output changes based on available cofactors and metabolic flow.
Another pattern that appears frequently is the overlap with histamine regulation. Histamine acts as both an immune molecule and a neurotransmitter. Its breakdown relies on enzymes such as DAO and HNMT, which are also connected to methylation and nutrient status. When histamine clearance is impaired, it can amplify nervous system reactivity. Individuals may experience anxiety, insomnia, skin reactions, or digestive symptoms that track with histamine fluctuations.
When looking across hundreds of reports, it becomes difficult to separate mental symptoms from biochemical processes. The nervous system is not operating independently of metabolism. It is directly shaped by it.
What changes outcomes is not forcing the system in one direction but stabilizing the inputs that regulate it. Consistent support of methylation without overdriving it, maintaining adequate vitamin C for redox balance, ensuring magnesium sufficiency for neuronal stability, and supporting cofactor availability for enzymes like MAOA all contribute to a more even pattern of neurotransmitter clearance.
When this happens, the cycling begins to reduce. Individuals report more consistent energy, fewer spikes in anxiety, improved sleep onset, and a greater ability to handle stress without becoming overwhelmed. The nervous system becomes more predictable because the chemistry driving it is more stable.
This is not a psychological reframe. It is a biochemical one. The patterns observed across these reports show that nervous system instability is often a reflection of how efficiently the body is regulating and clearing its own signaling molecules.
When those pathways are supported in alignment with the individual’s genetic structure, the system does not need to compensate as aggressively. It becomes more steady, more regulated, and more resilient under stress.